+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe L-Carnitine Market (2019-2025)

  • PDF Icon

    Report

  • 69 Pages
  • December 2019
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 4900372
The Europe L-Carnitine Market is expected to witness market growth of 3.91% CAGR during the forecast period (2019-2025).

L-carnitine is produced from the most commonly used chemical synthesis procedure called the chemical multistep racemization. It further generates a racemic mixture with D-carnitine as a byproduct. Usually, the process starts by including raw materials like epichlorohydrin and trimethylamine. It is followed by the separation of a racemic mixture through fractioned crystallization. Market players are aimed at providing their customers with a wide product portfolio, improved customer service, and increased value. In addition, they provide stand-alone or integrated, cost-effective solutions to help organizations. They put an extensive focus on providing their clients with customized products in order to achieve a competitive edge. In addition, these businesses ensure that their facilities are equipped with high technical skills and operational capability to provide their customers with integrated services.

The increased demand for commercial products has encouraged the manufacturers to optimize their production processes to gather improved yield. Microorganism and enzyme-based biological processes are fundamentally asymmetric processes. The most common bioprocess used in the development of L-carnitine with the highest yield is centered on biotransformation of achiral precursors like crotonobetain, 3-dehydrocarnitine, and p-butyrobetaine or racemic mixtures like D, L-carnitine, D, L-acyl carnitine, and D, L-carnitinamide.

Based on Product, the market is segmented into Food & Pharma Grade and Feed Grade. Based on Process, the market is segmented into Chemical Synthesis and Bioprocess. Based on Application, the market is segmented into Healthcare Product, Functional Drink, Medicine and Animal Food. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Lonza Group AG, Northeast Pharmaceutical Group Co. Ltd., Cayman Chemical Company, Inc., Tokyo Chemical Industry Co. Ltd., Ceva Sante Animale S.A., Kaiyuan Hengtai Chemical Co., Ltd., ChengDa Pharmaceuticals Co., Ltd., HuangGang HuaYang Pharmaceutical Co., Ltd., and HuBei YuanCheng SaiChuang Technology Co. Ltd.

Scope of the Study

Market Segmentation:

By Product
  • Food & Pharma Grade
  • Feed Grade

By Process
  • Chemical Synthesis
  • Bioprocess

By Application
  • Healthcare Product
  • Functional Drink
  • Medicine
  • Animal Food

By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled
  • Merck Group
  • Lonza Group AG
  • Northeast Pharmaceutical Group Co. Ltd.
  • Cayman Chemical Company, Inc.
  • Tokyo Chemical Industry Co. Ltd.
  • Ceva Sante Animale S.A.
  • Kaiyuan Hengtai Chemical Co., Ltd.
  • ChengDa Pharmaceuticals Co., Ltd.
  • HuangGang HuaYang Pharmaceutical Co., Ltd.
  • HuBei YuanCheng SaiChuang Technology Co. Ltd.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe L-Carnitine Market, by Product
1.4.2 Europe L-Carnitine Market, by Process
1.4.3 Europe L-Carnitine Market, by Application
1.4.4 Europe L-Carnitine Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe L-Carnitine Market by Product
3.1 Europe Food & Pharma Grade Market by Region
3.2 Europe Feed Grade Market by Region
Chapter 4. Europe L-Carnitine Market by Process
4.1 Europe Chemical Synthesis Market by Region
4.2 Europe Bioprocess Market by Region
Chapter 5. Europe L-Carnitine Market by Application
5.1 Europe Healthcare Product Market by Region
5.2 Europe Functional Drink Market by Region
5.3 Europe Medicine Market by Region
5.4 Europe Animal Food Market by Region
Chapter 6. Europe L-Carnitine Market by Region
6.1 Germany L-Carnitine Market
6.1.1 Germany L-Carnitine Market by Product
6.1.2 Germany L-Carnitine Market by Process
6.1.3 Germany L-Carnitine Market by Application
6.2 UK L-Carnitine Market
6.2.1 UK L-Carnitine Market by Product
6.2.2 UK L-Carnitine Market by Process
6.2.3 UK L-Carnitine Market by Application
6.3 France L-Carnitine Market
6.3.1 France L-Carnitine Market by Product
6.3.2 France L-Carnitine Market by Process
6.3.3 France L-Carnitine Market by Application
6.4 Russia L-Carnitine Market
6.4.1 Russia L-Carnitine Market by Product
6.4.2 Russia L-Carnitine Market by Process
6.4.3 Russia L-Carnitine Market by Application
6.5 Spain L-Carnitine Market
6.5.1 Spain L-Carnitine Market by Product
6.5.2 Spain L-Carnitine Market by Process
6.5.3 Spain L-Carnitine Market by Application
6.6 Italy L-Carnitine Market
6.6.1 Italy L-Carnitine Market by Product
6.6.2 Italy L-Carnitine Market by Process
6.6.3 Italy L-Carnitine Market by Application
6.7 Rest of Europe L-Carnitine Market
6.7.1 Rest of Europe L-Carnitine Market by Product
6.7.2 Rest of Europe L-Carnitine Market by Process
6.7.3 Rest of Europe L-Carnitine Market by Application
Chapter 7. Company Profiles
7.1 Merck Group
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.2 Lonza Group AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Acquisition and Mergers:
7.2.5.3 Product Launches and Product Expansions:
7.3 Northeast Pharmaceutical Group Co., Ltd. (NEPG)
7.3.1 Company Overview
7.4 Cayman Chemical Company, Inc.
7.4.1 Company Overview
7.5 Tokyo Chemical Industry Co., Ltd.
7.5.1 Company Overview
7.6 Ceva Sante Animale S.A.
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Acquisition and Mergers:
7.7 Kaiyuan Hengtai Chemical Co., Ltd.
7.7.1 Company Overview
7.8 ChengDa Pharmaceuticals Co. Ltd.
7.8.1 Company Overview
7.9 HuangGang HuaYang Pharmaceutical Co. Ltd.
7.9.1 Company Overview
7.1 HuBei YuanCheng SaiChuang Technology Co. Ltd.
7.10.1 Company Overview

Companies Mentioned

  • Merck Group
  • Lonza Group AG
  • Northeast Pharmaceutical Group Co. Ltd.
  • Cayman Chemical Company, Inc.
  • Tokyo Chemical Industry Co. Ltd.
  • Ceva Sante Animale S.A.
  • Kaiyuan Hengtai Chemical Co., Ltd.
  • ChengDa Pharmaceuticals Co., Ltd.
  • HuangG

Methodology

Loading
LOADING...